UB Paderborn / Katalog / Suche / in CDI

1 – 22 von 22

Sortiert nach

Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies

Journal of Virology, 2005-08, Vol.79 (16), p.10108-10125

2005

Link zum Volltext

Verfügbarkeit prüfen

Immunogenicity of a recombinant measles-HIV-1 clade B candidate vaccine

PloS one, 2012-11, Vol.7 (11), p.e50397-e50397

2012

Link zum Volltext

Verfügbarkeit prüfen

HIV-1 gp120 Vaccine Induces Affinity Maturation in both New and Persistent Antibody Clonal Lineages

Journal of Virology, 2012-07, Vol.86 (14), p.7496-7507

2012

Link zum Volltext

Verfügbarkeit prüfen

Extensively cross-reactive anti-HIV-1 neutralizing antibodies induced by gp140 immunization

Proceedings of the National Academy of Sciences - PNAS, 2007-06, Vol.104 (24), p.10193-10198

2007

Link zum Volltext

Verfügbarkeit prüfen

Heterologous prime-boost regimens with a recombinant chimpanzee adenoviral vector and adjuvanted F4 protein elicit polyfunctional HIV-1-specific T-Cell responses in macaques

PloS one, 2015-04, Vol.10 (4), p.e0122835-e0122835

2015

Link zum Volltext

Verfügbarkeit prüfen

Human Immunodeficiency Virus Type 1 Env Trimer Immunization of Macaques and Impact of Priming with Viral Vector or Stabilized Core Protein

Journal of Virology, 2009, Vol.83 (2), p.540-551

2009

Link zum Volltext

Verfügbarkeit prüfen

B cell recognition of the conserved HIV-1 co-receptor binding site is altered by endogenous primate CD4

PLoS pathogens, 2008-10, Vol.4 (10), p.e1000171-e1000171

2008

Link zum Volltext

Verfügbarkeit prüfen

Heterologous protection elicited by candidate monomeric recombinant HIV-1 gp120 vaccine in the absence of cross neutralising antibodies in a macaque model

Retrovirology, 2012-07, Vol.9 (1), p.56-56, Article 56

2012

Link zum Volltext

Verfügbarkeit prüfen

Immunogenicity of a recombinant measles HIV-1 subtype C vaccine

Vaccine, 2013-12, Vol.31 (51), p.6079-6086

2013

Link zum Volltext

Verfügbarkeit prüfen

Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutated

The Journal of experimental medicine, 2011-10, Vol.208 (11), p.2237-2249

2011

Link zum Volltext

Verfügbarkeit prüfen

Strong and persistent CD4+ T-cell response in healthy adults immunized with a candidate HIV-1 vaccine containing gp120, Nef and Tat antigens formulated in three Adjuvant Systems

Vaccine, 2010-10, Vol.28 (43), p.7016-7024

2010

Link zum Volltext

Verfügbarkeit prüfen

An Adjuvanted Polyprotein HIV-1 Vaccine Induces Polyfunctional Cross-Reactive CD4⁺ T Cell Responses in Seronegative Volunteers

Clinical infectious diseases, 2011-02, Vol.52 (4), p.522-531

2011

Link zum Volltext

Verfügbarkeit prüfen

A clinically relevant HIV-1 subunit vaccine protects rhesus macaques from in vivo passaged simian-human immunodeficiency virus infection

AIDS (London), 1998-03, Vol.12 (5), p.F15-F22

1998

Link zum Volltext

Verfügbarkeit prüfen

Toxicology, biodistribution and shedding profile of a recombinant measles vaccine vector expressing HIV-1 antigens, in cynomolgus macaques

Naunyn-Schmiedeberg's archives of pharmacology, 2012-12, Vol.385 (12), p.1211-1225

2012

Link zum Volltext

Verfügbarkeit prüfen

Induction of strong HIV-1-specific CD4+ T-cell responses using an HIV-1 gp120/NefTat vaccine adjuvanted with AS02A in antiretroviral-treated HIV-1-infected individuals

Journal of acquired immune deficiency syndromes (1999), 2012-01, Vol.59 (1), p.1

2012

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge model

Vaccine, 2007-03, Vol.25 (11), p.2145-2154

2007

Link zum Volltext

Verfügbarkeit prüfen

Definition of human immunodeficiency virus type 1 gp120 and gp41 cytotoxic T-lymphocyte epitopes and their restricting major histocompatibility complex class I alleles in simian-human immunodeficiency virus-infected rhesus monkeys

Journal of Virology, 1996-10, Vol.70 (10), p.7335-7340

1996

Link zum Volltext

Verfügbarkeit prüfen

Antibody responses after intravaginal immunisation with trimeric HIV-1 CN54 clade C gp140 in Carbopol gel are augmented by systemic priming or boosting with an adjuvanted formulation

Vaccine, 2011-02, Vol.29 (7), p.1421-1430

2011

Link zum Volltext

Verfügbarkeit prüfen

Cellular immune response to SIVmac and HIV-2 in macaques : model for the human HIV-1 infection

Journal of acquired immune deficiency syndromes (1988), 1993-09, Vol.6 (9), p.969-976

1993

Link zum Volltext

Verfügbarkeit prüfen

Human Immunodeficiency Virus Type 1 Envelope Glycoprotein-Specific Cytotoxic T Lymphocytes in Simian-Human Immunodeficiency Virus-Infected Rhesus Monkeys

Virology (New York, N.Y.), 1995-04, Vol.208 (2), p.770-775

1995

Link zum Volltext

Verfügbarkeit prüfen

1 – 22 von 22

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library Full Collection 2018

ThemaHiv-1 - Immunology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(22)

Sprache

Englisch
(22)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(20)
Humans
(16)
Life Sciences & Biomedicine
(16)
Aids Vaccines - Immunology
(15)
Animals
(14)
Virology
(14)
Human Immunodeficiency Virus 1
(13)
Biological And Medical Sciences
(11)
Hiv
(11)
Human Immunodeficiency Virus
(11)
Vaccines
(11)
Hiv Infections - Immunology
(10)
Immunology
(10)
Microbiology
(10)
Female
(9)
Hiv Antibodies - Blood
(9)
Male
(9)
Fundamental And Applied Biological Sciences. Psychology
(8)
Hiv Envelope Protein Gp120 - Immunology
(8)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies

Immunogenicity of a recombinant measles-HIV-1 clade B candidate vaccine

HIV-1 gp120 Vaccine Induces Affinity Maturation in both New and Persistent Antibody Clonal Lineages

A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults

Extensively cross-reactive anti-HIV-1 neutralizing antibodies induced by gp140 immunization

Heterologous prime-boost regimens with a recombinant chimpanzee adenoviral vector and adjuvanted F4 protein elicit polyfunctional HIV-1-specific T-Cell responses in macaques

Human Immunodeficiency Virus Type 1 Env Trimer Immunization of Macaques and Impact of Priming with Viral Vector or Stabilized Core Protein

B cell recognition of the conserved HIV-1 co-receptor binding site is altered by endogenous primate CD4

Heterologous protection elicited by candidate monomeric recombinant HIV-1 gp120 vaccine in the absence of cross neutralising antibodies in a macaque model

Immunogenicity of a recombinant measles HIV-1 subtype C vaccine

Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutated

Strong and persistent CD4+ T-cell response in healthy adults immunized with a candidate HIV-1 vaccine containing gp120, Nef and Tat antigens formulated in three Adjuvant Systems

An Adjuvanted Polyprotein HIV-1 Vaccine Induces Polyfunctional Cross-Reactive CD4⁺ T Cell Responses in Seronegative Volunteers

A clinically relevant HIV-1 subunit vaccine protects rhesus macaques from in vivo passaged simian-human immunodeficiency virus infection

Toxicology, biodistribution and shedding profile of a recombinant measles vaccine vector expressing HIV-1 antigens, in cynomolgus macaques

Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteers

Induction of strong HIV-1-specific CD4+ T-cell responses using an HIV-1 gp120/NefTat vaccine adjuvanted with AS02A in antiretroviral-treated HIV-1-infected individuals

Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge model

Definition of human immunodeficiency virus type 1 gp120 and gp41 cytotoxic T-lymphocyte epitopes and their restricting major histocompatibility complex class I alleles in simian-human immunodeficiency virus-infected rhesus monkeys

Antibody responses after intravaginal immunisation with trimeric HIV-1 CN54 clade C gp140 in Carbopol gel are augmented by systemic priming or boosting with an adjuvanted formulation

Cellular immune response to SIVmac and HIV-2 in macaques : model for the human HIV-1 infection

Human Immunodeficiency Virus Type 1 Envelope Glycoprotein-Specific Cytotoxic T Lymphocytes in Simian-Human Immunodeficiency Virus-Infected Rhesus Monkeys

Aktive Filter

Suchergebnisse filtern